ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 666

Sensitivity to Change of the Patient Reported Outcomes Measurement Information System (PROMIS) Computerized Adaptive Test (CAT) Measures in a Single Canadian Lupus Cohort

William Fung1, Mitra Moazzami 2, Lisa Engel 3, Jiandong Su 4, Dennisse Bonilla 4, Pooneh Akhavan 5, Patricia Katz 6, Dorcas Beaton 7 and Zahi Touma 8, 1University of Toronto, Toronto, ON, Canada, 2George Washington University, Washington, DC, 3University of Manitoba, Winnipeg, MB, Canada, 4University Health Network, University of Toronto, Toronto, ON, Canada, 5University of Toronto, Toronto, Canada, 6University of California, San Francisco, san francisco, CA, 7St. Michael's Hospital, Toronto, ON, Canada, 8University Health Network, University of Toronto, Toronto, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: SLE – Clinical Poster I: Epidemiology & Pathogenesis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Patient-reported outcomes (PROs) measures are a key component of the care of patients with systemic lupus erythematosus (SLE). The Patient Reported Outcomes Measurement Information System (PROMIS) computerized adaptive test (CAT) is a recently developed PRO instrument that has not yet been well studied in SLE. This study seeks to examine the sensitivity to change of PROMIS CAT compared to patient-reported anchors within a cohort of adult SLE patients.

Methods: All consecutive adult (≥18 years old) English-speaking patients with SLE and visiting the Toronto Lupus Clinic between July-September 2018 were approached to participate. Patients completed PROMIS CAT during their clinical visit assessing 14 domains. 89 patients completed PROMIS CAT at baseline and at 3-month follow-up. At 3 months, the generic anchor question “Compared to when you started the study, how have you been during the last 48 hours? (responses: same, worse, )” was asked to identify two subsets of patients, those with improved vs worsened symptoms at 3 months. Similar domain-specific anchor questions were asked at 3 months, with responses graded from -7 (greatest worsening) to +7 (greatest improvement), and 0 representing no change. For domain-specific anchors, patients were deemed to have improved if they graded >1, and worsened if < -1. Responsiveness was evaluated using standardized response means (SRM), with higher SRM values reflecting greater sensitivity to change (0.3-0.5 low, 0.5-0.8 moderate, >0.8 high). SRMs for each domain were determined with respect to the generic as well as domain-specific anchors. We hypothesized that domains demonstrate worsening and improvement in concordance with the anchors.

Results: Patient characteristics are in Table 1. Table 2 contains the baseline characteristics of the subsets of patients with improvement and worsening at follow-up.

With respect to the general anchor, of 14 PROMIS domains, 8 demonstrated moderate SRMs: mobility, pain behaviour, pain interference, participation in social roles, fatigue, anxiety, depression, and cognitive function abilities (Table 3).

For domain-specific anchors (Table 3), only 3 domains (pain behaviour, pain interference, depression) demonstrated moderate SRMs. Only 1 domain (satisfaction in social roles) had a high SRM. SRM were overall larger with the generic anchor compared to domain-specific anchor.

Conclusion: Out of 14 PROMIS domains, 8 were sensitive to change at 3-month follow-up when compared to a generic anchor question. In contrast, for domain-specific anchors, only 4 domains were sensitive to change at 3-month follow-up, of which one had not been sensitive in the generic anchor analysis. This highlights the importance of using appropriate anchor questions when assessing responsiveness. Focusing on patients with more significant reported changes (+/- 4-7 on anchors) may yield larger SRMS.   This requires a larger sample size and currently cannot be performed.  Further work is needed to evaluate the utility of PROMIS CAT measures in the care of lupus patients as well as to determine minimal clinically important differences.


Disclosure: W. Fung, None; M. Moazzami, None; L. Engel, None; J. Su, None; D. Bonilla, None; P. Akhavan, None; P. Katz, None; D. Beaton, None; Z. Touma, None.

To cite this abstract in AMA style:

Fung W, Moazzami M, Engel L, Su J, Bonilla D, Akhavan P, Katz P, Beaton D, Touma Z. Sensitivity to Change of the Patient Reported Outcomes Measurement Information System (PROMIS) Computerized Adaptive Test (CAT) Measures in a Single Canadian Lupus Cohort [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/sensitivity-to-change-of-the-patient-reported-outcomes-measurement-information-system-promis-computerized-adaptive-test-cat-measures-in-a-single-canadian-lupus-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sensitivity-to-change-of-the-patient-reported-outcomes-measurement-information-system-promis-computerized-adaptive-test-cat-measures-in-a-single-canadian-lupus-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology